on biotechnology investments specifically and pioneered direct-equity investments of BMGF in companies with platform technologies such as Liquidia, Genocea, Visterra, Atreca, and Anacor. At BMGF, Dr. Nikolic also led the discovery program of the novel mHealth, diagnostics platform technologies, molecular diagnos